[1]蒋忠洋,孙 欢,马世伟,等.右美托咪啶联合瑞芬太尼在ICU患者镇痛镇静中的应用观察*[J].陕西医学杂志,2020,49(3):341-344,348.
 JIANG Zhongyang,SUN Huan,MA Shiwei,et al.Application of dexmedetomidine combined with remifentanil in analgesia and sedation of ICU patients[J].,2020,49(3):341-344,348.
点击复制

右美托咪啶联合瑞芬太尼在ICU患者镇痛镇静中的应用观察*
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
49
期数:
2020年3期
页码:
341-344,348
栏目:
药物与临床
出版日期:
2020-03-05

文章信息/Info

Title:
Application of dexmedetomidine combined with remifentanil in analgesia and sedation of ICU patients
文章编号:
DOI:〖HT5K〗10.3969/j.issn.10007377.2020.03.020
作者:
蒋忠洋孙 欢马世伟刘渝鹏贾 超
四川省绵阳市中心医院重症医学科(绵阳 621000)
Author(s):
JIANG ZhongyangSUN HuanMA Shiweiet al.
Department of Critical Care Medicine,Mianyang Central Hospital,Sichuan Province(Mianyang 621000)
关键词:
重症监护病房 镇静 镇痛 右美托咪啶 瑞芬太尼
Keywords:
Intensive care unit Sedation Analgesia Dexmedetomidine Remifentanil
分类号:
R614.2
文献标志码:
A
摘要:
目的:研究右美托咪啶联合瑞芬太尼在ICU镇痛镇静治疗中的应用效果及作用机制。方法:采用简单随机抽样选取ICU住院患者92例,采用随机数字表法均分为观察组和对照组各46例。两组均在液体复苏、抗感染以及营养支持等综合干预基础上采用瑞芬太尼进行镇痛治疗,观察组另加用右美托咪定,对照组加用丙泊酚,比较两组治疗结局、血流动力学指标、呼吸功能、应激反应水平及不良反应发生情况。结果:观察组瑞芬太尼用量、ICU住院时间及谵妄发生率均明显低于对照组(P<0.05),两组ICU病死率比较差异无统计学意义(P>0.05); 观察组治疗后平均动脉压(MAP)、肺毛细血管楔嵌压(PCWP)和心输出量(CO)均无明显变化(P>0.05),对照组MAP明显升高(P<0.05),CO明显降低(P<0.05),且观察组MAP低于对照组,CO高于对照组; 观察组吸气末跨肺压(Ptp-ei)、呼气末跨肺压(Ptp-ee)以及驱动压(△Ptp)均无明显变化,对照组Ptp-ei和△Ptp均明显升高(P<0.05),Ptp-ee明显降低(P<0.05),且观察组Ptp-ei和Ptp-ee高于对照组,△Ptp低于对照组; 两组血糖(Glu)、皮质醇(Cor)及去甲肾上腺素(NE)水平均明显降低(P<0.05),且观察组Glu、Cor和NE低于对照组,差异均有统计学意义(P<0.05); 观察组治疗期间发生恶心呕吐2例(4.35%),呼吸抑制3例(6.52%); 对照组发生恶心呕吐4例(8.70%),呼吸抑制5例(10.87%),心动过缓1例(2.17%); 两组不良反应比较差异无统计学意义(P>0.05)。结论:右美托咪啶联合瑞芬太尼用于ICU患者镇痛镇静治疗有利于减少谵妄发生和促进患者康复,同时对维持患者呼吸循环功能稳定,减轻机体应激反应水平和不良反应发生也具有积极作用。
Abstract:
Objective:To study the effect and mechanism of dexmedetomidine combined with remifentanil in analgesia and sedation in ICU.Methods:A total of 92 inpatients admitted to ICU were selected by simple random sampling and divided into observation group and control group according to the random number table method,with 46 cases in each group.The two groups were given remifentanil for analgesia therapy on the basis of comprehensive interventions of fluid resuscitation,anti-infection and nutritional support,and observation group was supplemented with dexmedetomidine while control group was supplemented with propofol.The treatment outcomes,hemodynamic parameters,respiratory function,stress response level and occurrence of adverse reactions were compared between the two groups.Results:The dosage of remifentanil,ICU stay and incidence rate of delirium in observation group were significantly lower than those in control group(P<0.05),and there was no significant difference in mortality rate in ICU between the two groups(P>0.05).After treatment,there were no significant changes in the mean arterial pressure(MAP),pulmonary capillary wedge pressure(PCWP)and cardiac output(CO)in observation group(P>0.05),and the MAP in control group was significantly increased(P<0.05)while the CO was significantly decreased(P<0.05),and the MAP in observation group was lower than that in control group while the CO was higher than that in control group.There were no significant changes in the end-inspiratory transpulmonary pressure(Ptp-ei),end-expiratory transpulmonary pressure(Ptp-ee)and driving pressure(△Ptp)in observation group,and the Ptp-ei and △Ptp in control group were significantly increased(P<0.05)while the Ptp-ee was significantly decreased(P<0.05),and the Ptp-ei and Ptp-ee in observation group were higher than those in control group while the △Ptp was lower than that in control group.The levels of blood glucose(Glu),cortisol(Cor)and norepinephrine(NE)were significantly decreased in the two groups(P<0.05),and the levels of Glu,Cor and NE in observation group were lower than those in control group(P<0.05).There were 2 cases(4.35%)of nausea and vomiting,and 3 cases(6.52%)of respiratory depression during treatment in observation group,and there were 4 cases(8.70%)of nausea and vomiting,5 cases(10.87%)of respiratory depression and 1 case(2.17%)of bradycardia in control group.There were no significant differences in adverse reactions between the two groups(P>0.05).Conclusion:Dexmedetomidine combined with remifentanil for analgesia and sedation in patients in ICU is beneficial to reduce the occurrence of delirium and promote the rehabilitation of patients.It also has positive significance in maintaining the stability of respiratory circulation function and reducing the body's stress response and occurrence of adverse reactions.

参考文献/References:

[1] 中华医学会重症医学分会.中国成人ICU镇痛和镇静治疗指南[J].中华危重病急救医学,2018,30(6):497-514.
[2] Faust AC,Rajan P,Sheperd LA,et al.Impact of an analgesia-based sedation protocol on mechanically ventilated patients in a medical intensive care unit[J].Anesth Analg,2016,123(4):903-909.
[3] 王晓燕,金立民,周春燕,等.氟比洛芬酯复合右美托咪定对瑞芬太尼诱发患者术后痛觉过敏的影响[J].中国实验诊断学,2016,20(9):1572-1574.
[4] 胡雅姣,李 羽.右美托咪定在神经外科麻醉中的应用与研究进展[J].中国药业,2019,28(15):96-99.
[5] Song Y,Shim JK,Song JW,et al.Dexmedetomidine added to an opioid- based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients:A randomised controlled trial[J].Eur J Anaesthesiol,2016,33(2):75-83.
[6] 王健叶,刘 蓉.ICU患者的心理问题原因分析及护理干预措施[J].中华全科医学,2011,9(10):1588-1589.
[7] 杜 微,王小亭,刘大为.镇痛镇静治疗的血流动力学效应,你该知道[J].中华内科杂志,2018,57(3):164-167.
[8] 焦 阳,朱家旺.ICU镇痛和镇静的药物治疗策略和进展[J].海峡药学,2015(9):139-141.
[9] Chaoliang T,Zhongyuan X.Dexmedetomidine in perioperative acute pain management:a non-opioid adjuvant analgesic[J].J Pain Res,2017,10:1899-1904.
[10] 王晓旋,刘昳聪,赵秀娟,等.右美托咪啶在重症监护病房中的应用[J].中国新药杂志,2017,26(10):1144-1147.
[11] Butler M,Froese P,Zed P,et al.Emergency department procedural sedation for primary electrical cardioversion- a comparison with procedural sedations for other reasons[J].World J Emerg Med,2017(3):7-11.
[12] 应满珍,杜凯磊,吴木莹.右美托咪啶对ICU非机械通气患者浅镇静的临床研究[J].中华急诊医学杂志,2018,27(12):1407-1408.
[13] Hernandez G,Tapia P,Alegria L,et al.Effects of dexmedetomidine and esmolol on systemic hemodynamics and exogenous lactate clearance in early experimental septic shock[J].Criti Care,2016,20(1):234.
[14] 胡 腾,张占军,刘仁伟,等.右美托咪啶在老年患者心脏手术中的临床应用[J].中国现代医学杂志,2018,28(18):111-114.
[15] Dhasmana SC,Pal M,Singh V,et al.Erratum to:Nasotracheal fiberoptic intubation:patient comfort,intubating conditions and hemodynamic stability during conscious sedation with different doses of dexmedetomidine[J].J Maxillofac Oral Surg,2014,13(1):53-58.
[16] 刘 军,罗积慎,殷 辉,等.盐酸右美托咪定对ICU患者气管插管应激反应的影响[J].药物评价研究,2017,40(9):1319-1322.
[17] 崔士和,蒋 忠.等效镇痛剂量芬太尼、瑞芬太尼和舒芬太尼对维吾尔族患者镇静及副作用影响的对比研究[J].现代医学,2016,44(2):187-190.
[18] 姜晓东,付新磊,于 健.瑞芬太尼联合右美托咪定在ICU机械通气患者镇痛镇静中的作用[J].大连医科大学学报,2018,40(5):408-411,423.

相似文献/References:

[1]何 侣,刘明全△,缪 航,等.重症监护病房支气管哮喘急性发作患者真菌感染高危因素分析*[J].陕西医学杂志,2020,49(3):292.
 HE Lv,LIU Mingquan,MIAO Hang,et al.High-risk factors of fungus infection in patients with acute attack of bronchial asthma in intensive care unit[J].,2020,49(3):292.
[2]刘宏飞,霍鹏伟△.超声引导下腰丛-坐骨神经阻滞与硬膜外麻醉用于老年膝关节置换术对比研究*[J].陕西医学杂志,2020,49(8):947.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.009]
 LIU Hongfei,HUO Pengwei..Comparative study of ultrasound-guided lumbar plexus-sciatic nerve block and epidural anesthesia for knee replacement in elderly[J].,2020,49(3):947.[doi:DOI:10.3969/j.issn.1000-7377.2020.08.009]
[3]王 丽,郭帅锋,李书平,等.右美托咪定不同方案对胸外科术后患者镇痛效果临床观察[J].陕西医学杂志,2023,52(9):1228.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.027]
 WANG Li,GUO Shuaifeng,LI Shuping,et al.Ananlgesic effects of different regimens of dexmedetomidine on patients after thoracic surgery[J].,2023,52(3):1228.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.027]
[4]赵海霞,肖 婷,胡 敏,等.基于肠内营养耐受性评估表的早期肠内营养支持对重症监护病房患者疾病治疗的价值研究[J].陕西医学杂志,2024,(5):637.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.013]
 ZHAO Haixia,XIAO Ting,HU Min,et al.Value of early enteral nutrition support therapy for patients in intensive care unit based on enteral nutrition tolerance assessment sheet[J].,2024,(3):637.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.013]

备注/Memo

备注/Memo:
*四川省卫生健康委员会科研课题(199650117)
更新日期/Last Update: 2020-03-25